$PSNL
Personalis Inc
PRICE
$3.4 โผ-1.449%
Last Close
VOLUME
449,740
DAY RANGE
3.31 - 3.5788
52 WEEK
3.13 - 25.2
Join Discuss about PSNL with like-minded investors
@Benlax #droscrew
other than that got some nice prints on our high growth overlords: CRWD, VEEV, OZON, ETSY also some bio names like PSNL and CLPT great print on SNAP and both twtr and pins with solid prints as well great print on sklz nasty print on algn great print on ely great print on ACMR
113 Replies 8 ๐ 10 ๐ฅ
@Benlax #droscrew
heres one i forgot about but has been absolutely beasting it, may consider moving some psnl to it
104 Replies 13 ๐ 8 ๐ฅ
@Benlax #droscrew
genomics are particularly applicable in oncology where genetic tumor profiling is used to identify mutations and then select appropriate targeted drug for that mutation. Precision medicine at its finest. Thats is what i am most bullish on and thats exactly what PSNL does
134 Replies 11 ๐ 12 ๐ฅ
Key Metrics
Market Cap
154.52 M
Beta
2.05
Avg. Volume
881.83 K
Shares Outstanding
45.45 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-04
Next Dividend Date
Company Information
Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA MVP. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient's cancer and immune response. The Personalisยฎ ImmunoID NeXT Platformยฎ is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The PersonalisClinical Laboratory is GxP-aligned as well as CLIA'88-certified and CAP-accredited.
CEO: John West
Website: www.personalis.com
HQ: 1330 Obrien Dr Menlo Park, 94025-1436 California
Related News